首页 > 产品目录 > 免疫学 > 抗体 > Anti-MTA2/PID antibody

Anti-MTA2/PID antibody

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
100ug
- +
产品详情
  • 产品名称

    Anti-MTA2/PID抗体
    参阅全部 MTA2/PID 一抗

  • 描述

    兔多克隆抗体to MTA2/PID

  • 宿主

    Rabbit

  • 特异性

    No cross-reactivity to MTA1.

  • 经测试应用

    适用于: IHC-FrELISAWBIHC-PICC/IFIPmore details

  • 种属反应性

    与反应: Mouse, Rat, Human

  • 免疫原

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • 常规说明


    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Store at +4°C.

  • 存储溶液

    pH: 7.2
    Preservative: 0.02% Sodium azide

  • 浓度

    • 100 µg 浓度为 1 mg/ml

  • 纯度

    Affinity purified

  • 克隆

    多克隆

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab8106于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
IHC-Fr

Use at an assay dependent concentration. PubMed: 18413351

ELISA

Use at an assay dependent concentration.

WB(1)

Use a concentration of 0.5 - 1 µg/ml. Detects a band of approximately 75 kDa (predicted molecular weight: 75 kDa).

IHC-P

Use at an assay dependent concentration.

ICC/IF

Use a concentration of 10 µg/ml.

IP(1)

Use at an assay dependent concentration.

  • 数据库链接

  • 别名

    • Metastasis associated 1 like 1 antibody

    • Metastasis associated gene 1 like 1 antibody

    • Metastasis associated gene family member 2 antibody

    • Metastasis associated protein 2 antibody

    • Metastasis associated protein MTA 2 antibody

    • Metastasis associated protein MTA2 antibody

    • Metastasis-associated 1-like 1 antibody

    • Metastasis-associated protein MTA2 antibody

    • Mmta2 antibody

    • MTA1 L1 protein antibody

    • MTA1-L1 protein antibody

    • MTA1L1 antibody

    • MTA2 antibody

    • MTA2_HUMAN antibody

    • p53 target protein in deacetylase complex antibody

    • PID antibody

    • DKFZp686F2281 antibody

    • Mata1l1 antibody

    • Metastasis associated 1 family member 2 antibody

  • Western blot - Anti-MTA2/PID antibody (ab8106)

    Western blot - Anti-MTA2/PID antibody (ab8106)

    All lanes : Anti-MTA2/PID antibody (ab8106) at 1 µg/ml

    Lane 1 : HeLa whole cell lysate with absence of blocking peptide
    Lane 2 : HeLa whole cell lysate with presence of blocking peptide

    Predicted band size: 75 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-MTA2/PID antibody (ab8106)

    Immunocytochemistry/ Immunofluorescence - Anti-MTA2/PID antibody (ab8106)

    ab8106 at 10µg/ml staining MTA2/PID in Hela cells by ICC/IF

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA2/PID antibody (ab8106)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA2/PID antibody (ab8106)

    ab8106 (2µg/ml) staining MTA2/PID in human ileum using an automated system (DAKO Autostainer Plus). Using this protocol there is strong nuclear staining.
    Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

  • Immunocytochemistry/ Immunofluorescence - Anti-MTA2/PID antibody (ab8106)

    Immunocytochemistry/ Immunofluorescence - Anti-MTA2/PID antibody (ab8106)

    Immunofluorescence of PID in HeLa cells using ab8106 at 10 ug/ml.